Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease
Related Posts
Mauldin K, Pham AD, Dodaballapur S, Limketkai BN. Artificial Intelligence in Clinical Nutrition: Current Uses, Challenges, and Opportunities. Nutrients. 2026 Aug 12;18(16):2638. doi: 10.3390/nu18162638. PMID:[...]
Aoki A, Jacobs JP, Okamoto Y. Sucralose Alters Gut Microbiota, Intestinal Metabolites, and Epithelial Serotonergic Responses to Visceral Stimulation in Mice Exposed to Chronic Restraint[...]
van Bokhorst QNE, Yarra S, van der Vlugt M, Pohl H, Dekker E, Shaukat A; SCOPE initiative collaborators. Standardized Assessment of Complete Colorectal Polyp Resection[...]